We constructed Ba/F3 cells carrying BCR::ABL1 mutants by gene cloning technology and compared the effects of combination therapy with those of monotherapy on the biological characteristics and signaling pathways in CML cells. Here, ABL1 is linked to chronic myelogenous leukemia, BCR-ABL1 positive.